Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers
Phase 2
Completed
- Conditions
- Covid-19
- First Posted Date
- 2021-05-26
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- RUTI Immunotherapeutics S.L.
- Target Recruit Count
- 251
- Registration Number
- NCT04903184
- Locations
- 🇦🇷
Hospital General de Agudos Dr. Ignacio Pirovano, Buenos Aires, Argentina
🇦🇷Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
🇦🇷Hospital General, Mendoza, Argentina
News
No news found